1. Home
  2. IBN vs SNY Comparison

IBN vs SNY Comparison

Compare IBN & SNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IBN
  • SNY
  • Stock Information
  • Founded
  • IBN 1955
  • SNY 1994
  • Country
  • IBN India
  • SNY France
  • Employees
  • IBN N/A
  • SNY 82878
  • Industry
  • IBN Commercial Banks
  • SNY Biotechnology: Pharmaceutical Preparations
  • Sector
  • IBN Finance
  • SNY Health Care
  • Exchange
  • IBN Nasdaq
  • SNY Nasdaq
  • Market Cap
  • IBN 108.2B
  • SNY 119.4B
  • IPO Year
  • IBN 1999
  • SNY N/A
  • Fundamental
  • Price
  • IBN $30.74
  • SNY $50.05
  • Analyst Decision
  • IBN
  • SNY Buy
  • Analyst Count
  • IBN 0
  • SNY 4
  • Target Price
  • IBN N/A
  • SNY $61.50
  • AVG Volume (30 Days)
  • IBN 4.5M
  • SNY 2.2M
  • Earning Date
  • IBN 10-18-2025
  • SNY 10-24-2025
  • Dividend Yield
  • IBN 0.69%
  • SNY 3.25%
  • EPS Growth
  • IBN 11.76
  • SNY 105.93
  • EPS
  • IBN 0.83
  • SNY 8.67
  • Revenue
  • IBN $21,493,768,246.00
  • SNY $53,890,648,839.00
  • Revenue This Year
  • IBN N/A
  • SNY $2.37
  • Revenue Next Year
  • IBN $13.41
  • SNY $6.51
  • P/E Ratio
  • IBN $18.29
  • SNY $5.68
  • Revenue Growth
  • IBN 16.53
  • SNY N/A
  • 52 Week Low
  • IBN $27.42
  • SNY $44.62
  • 52 Week High
  • IBN $34.57
  • SNY $60.12
  • Technical
  • Relative Strength Index (RSI)
  • IBN 47.24
  • SNY 49.85
  • Support Level
  • IBN $30.75
  • SNY $49.14
  • Resistance Level
  • IBN $31.32
  • SNY $52.67
  • Average True Range (ATR)
  • IBN 0.34
  • SNY 0.76
  • MACD
  • IBN 0.03
  • SNY -0.24
  • Stochastic Oscillator
  • IBN 59.12
  • SNY 34.81

About IBN ICICI Bank Limited

ICICI Bank Ltd provides banking services. The company's operating segments include Retail Banking; Wholesale Banking; Treasury, Life insurance, Other Banking Business, and Others. The company generates maximum revenue from the Retail Banking segment which includes exposures of the Bank, which satisfy the four qualifying criteria of a regulatory retail portfolio as stipulated by RBI guidelines on the Basel III framework as well as includes income from credit cards, debit cards, third party product distribution, and the associated costs. Geographical segments include Domestic operations and Foreign operations. The company generates the majority of its revenue from the domestic operations.

About SNY Sanofi ADS

Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for approximately 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.

Share on Social Networks: